These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8968295)

  • 1. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
    Scalabrin DM; Solé D; Naspitz CK
    J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems.
    Scalabrin DM; Naspitz CK
    J Asthma; 1993; 30(1):51-9. PubMed ID: 8428859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
    Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
    Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of terbutaline and fenoterol unit dose vials in treating children with acute asthmatic attacks.
    Lin YZ; Huang FY
    Acta Paediatr Taiwan; 2002; 43(4):187-92. PubMed ID: 12238905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
    Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
    Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE
    Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of different nebulized bronchodilators on clinical efficacy and hypokalemia in asthmatic children.
    Hung CH; Hua YM; Lee MY; Tsai YG; Yang KD
    Acta Paediatr Taiwan; 2001; 42(5):287-90. PubMed ID: 11729705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 12. [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
    Budmiger H; Kyd K; Scherrer M
    Schweiz Med Wochenschr; 1978 Aug; 108(31):1190-7. PubMed ID: 675213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects.
    Svedmyr N
    Pharmacotherapy; 1985; 5(3):109-26. PubMed ID: 2991865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
    Gunn SD; Ayres JG; McConchie SM
    Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis.
    Minette A; Marcq M; Gepts L
    Bull Eur Physiopathol Respir; 1976; 12(4):545-53. PubMed ID: 13895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: a dose-response study.
    Bennis J; Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():113-7. PubMed ID: 343234
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients.
    Lötvall J; Lunde H; Svedmyr N
    Can Respir J; 1998; 5(3):191-4. PubMed ID: 9707465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.